ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened at $7.73 in last session, and closed at $7.69, while the day range of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock is $7.53 – $8.14. The stock showed a positive weekly performance of -12.11%.
Pfizer Inc. (NYSE:PFE) on Mar. 6 is voluntarily recalling one lot of 30-count Effexor XR® (venlafaxine HCl) 150 mg extended-release capsules, one lot of 90-count Effexor XR (venlafaxine HCl) 150 mg extended-release capsules and one lot of 90-count Greenstone LLC-branded Venlafaxine HCl 150 mg extended-release capsules. Pfizer Inc. (NYSE:PFE) stock opened at $32.35 in last session, and closed at $32.42 by gaining 0.09%. The 52 week range of $27.12 – $32.96. Company’s market capitalization is $220.88 billion.
Novavax, Inc. (NASDAQ:NVAX) on Mar. 10 reported its financial results for the fourth quarter and year ended December 31, 2013 and announced the initiation of a Phase 1/2 clinical trial of its H7N9 avian influenza VLP vaccine candidate with its proprietary Matrix-M adjuvant. Novavax, Inc. (NASDAQ:NVAX) stock increased 0.68% and finished the last session at $5.90. The EPS of the stock remained -0.30. Company’s market capitalization is $994.37 million.
Cell Therapeutics Inc. (NASDAQ:CTIC) on Mar. 4 reported financial results for the fourth quarter and full year ended Dec. 31, 2013. Cell Therapeutics Inc. (NASDAQ:CTIC) stock opened the session at $3.74, and closed the session at $3.79. The 52 week range of the Cell Therapeutics Inc. (NASDAQ:CTIC) stock remained $0.97 – $4.25 and the day range was $3.73 – $4.03.
Leave a Reply